The several ways to authentically cure Alzheimer's dementia.
Alzheimer’s dementia
EMT
Genuine cure
Multiple drugs
Multiple types
Non-generalizable
TGF-β
Treatment options
Wnt/β-catenin
Journal
Ageing research reviews
ISSN: 1872-9649
Titre abrégé: Ageing Res Rev
Pays: England
ID NLM: 101128963
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
29
08
2023
revised:
11
10
2023
accepted:
11
10
2023
pubmed:
22
10
2023
medline:
22
10
2023
entrez:
21
10
2023
Statut:
ppublish
Résumé
Although drugs may slow its progression, authentic cure of AD has never been accomplished. Here, six approaches are suggested that might achieve genuine cure. The six therapies include: 1) treatments addressing levels of TGF-β and Wnt/β-catenin, that become significantly reduced after MCI transitions to AD, and addressing also the impaired epithelial-to-mesenchymal transition (EMT) in AD's pathogenesis; 2) and 3) are two formulations that address the inadequate counter-responses to initial loss of cognition; 4) treatments addressing the brain cells whose impaired functions result in MCI and dementia; 5) the need for using partner drugs even when a particular drug addresses a single pathogenetic cause such as amyloid deposition; 6) enhancing the likelihood of genuine cure by using combinations of approaches chosen from the foregoing. Briefly, genuine cure of AD is possible; however, since AD denotes not one but multiple, phenotypically similar conditions, no one therapy can be generalized to all cases.
Identifiants
pubmed: 37865143
pii: S1568-1637(23)00252-0
doi: 10.1016/j.arr.2023.102093
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
102093Informations de copyright
Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest There were no funds received for this article, and there are no conflicts of interest.